(3aR)-Selitrectinib is a potent TRK kinase inhibitor, demonstrating IC50 values of 0.6 nM for TRKA and less than 2.5 nM for TRKC. This next-generation compound is designed to target TRK signaling pathways, making it a valuable tool in cancer research. Its selective inhibition of TRK kinases can aid in the investigation of tumorigenesis and the therapeutic potential in TRK fusion-positive cancers.
(3aR)-Selitrectinib is a potent TRK kinase inhibitor, demonstrating IC50 values of 0.6 nM for TRKA and less than 2.5 nM for TRKC. This next-generation compound is designed to target TRK signaling pathways, making it a valuable tool in cancer research. Its selective inhibition of TRK kinases can aid in the investigation of tumorigenesis and the therapeutic potential in TRK fusion-positive cancers.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: